Latest filing published 30 May 2025 for Checkpoint Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Christian Bechon, listed as board member, appears in our data through filings on Checkpoint Therapeutics, Inc. shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 10 June 2021 to 28 May 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 30 May 2025, the filings show a share grant in Checkpoint Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations